TABLE 2.
Organism | Primer | Sequence (5′→3′)a | Primer concn (μM) | Product length (bp) | Target geneb | Source or reference |
---|---|---|---|---|---|---|
Group 1 | ||||||
Influenza A virus | FluARe-F1 | AAGACCAATCCTGTCACCTCTGA | 0.103 | 104 | Matrix | 30 |
FluARe-R1 | CAAAGCGTCTACGCTGCAGTCC | 0.103 | ||||
Influenza A virus H1 | H1-IF2 | TCGCCGACTATGAGGAACTGAGGGA | 0.021 | 431 | Hemagglutinin | This study |
H1-IR2 | TTGTATCCCCGGGTTCCAGCAGAGT | 0.021 | ||||
Influenza A virus H3 | H3-IF2 | CCCTTATGATGTGCCGGATTATGCC | 0.205 | 259 | Hemagglutinin | This study |
H3-IR2 | GGTGGTGAACCCCCCAAATGTACAA | 0.205 | ||||
Influenza A virus H5 | H5N1-VIET-1A | TGCGACTGGRCTCAGAAATA | 0.512 | 172 | Hemagglutinin | This study |
H5N1-VIET-4B | GGATTCTTTGTCTGCAGCGT | 0.512 | ||||
Influenza B virus | FLUB-IF3 | AAAACAARTGCTCTGCRCCYCAAC | 0.41 | 516 | Nucleoprotein | This study |
FLUB-IR3 | CRTCTCCACCTACTTCRTTYCCCCC | 0.41 | ||||
Group 2 | ||||||
PIV-1 | PIV-1-IF1 | AATTGGTGATGCAATATATGCKTATTC | 0.61 | 600 | Hemagglutinin-neuraminidase | This study |
PIV-1-IR1 | TCGACAACAATYTTTGGCCTATC | 0.61 | ||||
PIV-2 | PIV2-F2 | AGGACAGCAGAGGACCTCGGCATG | 0.0305 | 343 | Hemagglutinin-neuraminidase | This study |
PIV2-R2 | ACCTGATGTTCTTTGCGGTATGGGG | 0.0305 | ||||
PIV-3 | PIV-3-IF1 | CAACTGTGTTCRACTCCCAAAG | 0.457 | 717 | Hemagglutinin-neuraminidase | This study |
PIV-3-IR1 | TGGGTTYACTCTCGATTTTTGY | 0.457 | ||||
PIV-4 | PIV-4AB-IF2 | GACGGATGYYTRCKGWATTGTGT | 0.153 | 231 | Hemagglutinin-neuraminidase | This study |
PIV-4AB-IR2 | CCRTRAGRCCYCCATACAARGGAA | 0.153 | ||||
Group 3 | ||||||
hRSV A | RSVA-IF2 | TGACCCATTAGTGTTCCCCTCTGATGAAT | 0.278 | 228 | Fusion protein | This study |
RSVA-IR2 | CTTCTGGCCTTRCAGTATARGAGCAGT | 0.278 | ||||
hRSV B | RSV-B-IF1 | GTCGCATCTCCAACATTGRAAC | 0.069 | 336 | Fusion protein | This study |
RSV-B-IR1 | TGGTGCATAGAGGTGATGTGTG | 0.069 | ||||
hRV | RV-OF2 | CACTTCTGTTTCCCCGGAGCGAGG | 0.139 | 283 | 5′ UTR | 14 |
JWA-1B-MOD-RV | CCGCATTCAGGGGCCGGAG | 0.139 | ||||
hEV | EV-IF3 | CCTCCGGCCCCTGAATGCG | 0.139 | 106 | 5′ UTR | 3, 14 |
EV-IR3 | CCAAAGTAGTCGGTTCCGCYRCRGA | 0.139 | ||||
Group 4 | ||||||
HCoV-OC43 | HCoVOC43-IF2 | CKGTGCCCTCTCCATTAAATTGGG | 0.25 | 635 | Spike protein | This study |
HCoVOC43-IR2 | GACCCGAACAGTGCTCACCTATGCC | 0.25 | ||||
SARS-CoV | COR3 | AGTGAGATGGTCATGTGTGG | 0.5 | 210 | Polymerase | 32 |
COR4 | CACTCATAGAGCCTGTGTTG | 0.5 | ||||
HCoV-229E | COR229E-IF3 | TTGGGATTCTAATTGGGCCTTTGTTGC | 0.25 | 361 | Matrix | This study |
COR229E-IR3 | GCTCGGCACGGCAACTGTCATGTAT | 0.25 | ||||
hMPV | Meta-M-IF2 | CCCTTTGTTTCAGGCCAAYACACCACC | 0.25 | 431 | Matrix protein | 2 |
Meta-M-IR2 | GCAGCTTCAACAGTRGCTGATTCACTCTC | 0.25 | ||||
Group 5 | ||||||
M. pneumoniae | Mpneumoniae-OF1 | AGGGGGTTCTTCAGGCTCAGGTCAA | 0.094 | 160 | Cytadhesin P1 gene | 17 |
Mpnuemoniae-OR1 | CCCCACCACATCATTCCCCGTATTA | 0.094 | ||||
C. pneumoniae | Chlamy-pneum-IF6 | RCCTACWGGATCCGCTRCTGCRAA | 0.313 | 317 | Outer membrane protein A | 17 |
Chlamy-pneum-IR6 | GCRCCTACGCTCCAAGMRAAAGWRG | 0.313 | ||||
L. pneumophila | Legionella-IF1 | TGAAAACAAAAACAAGCCAGGCGTTG | 0.063 | 232 | Macrophage infectivity potentiator (“mip”) | This study |
Legionella-IR1 | TGGCATCAATTGYAAAGCYTCTGTCC | 0.063 | ||||
ADV | ADVAtoF-IF3 | TGGCYWSCACNTWCTTTGACATYMG | 0.782 | 463 | Hexogene | This study |
ADVAtoF-IR3 | GCRWAWGAHCCRTARCAKGGYTDCAT | 0.782 |
Degenerate primer abbreviations are as follows: M, A/C; R, A/G; W, A/T; S, C/G; Y, C/T; K, G/T; V, A/C/G; H, A/C/T; D, A/G/T; N, A/C/G/T.
UTR, untranslated region.